Recruiting OBSERVATIONAL NCT06216782
Exploring the Frontiers of Neoadjuvant Therapy for Lung Cancer: a Prospective Observational Real-world Study
Sponsor: Shanghai Pulmonary Hospital, Shanghai, China
Conditions
Lung Cancer
Interventions
Non-intervention
Updated 3 times since 2024 Last updated: Jan 11, 2024 Started: Dec 16, 2023 Primary completion: Dec 30, 2033 Completion: Dec 30, 2033
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06216782, this observational or N/A phase trial focuses on Lung Cancer and remains actively recruiting participants. Sponsored by Shanghai Pulmonary Hospital, Shanghai, China, it has been updated 3 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Feb 2024 — Jul 2024 [monthly]
Recruiting
First recorded
Dec 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Shanghai Pulmonary Hospital, Shanghai, China
Data source: Shanghai Pulmonary Hospital, Shanghai, China
For direct contact, visit the study record on ClinicalTrials.gov .